The race to develop vaccine for the coronavirus is not only shifting into high gear. It turns out, drug companies are following different maps to find the finish line. FULL STORY: ABC7 wants to help make the Bay Area an…
Dr. Mikael Dolsten, Pfizer Chief Science Officer breaks down the progress Pfizer is making in the development of the COVID-19 vaccine as they enter phase 3 trials. Subscribe to Yahoo Finance: About Yahoo Finance: At Yahoo Finance, you get free…
CNBC’s Meg Tirrell reports on Pfizer’s coronavirus vaccine trial. With CNBC’s Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Brian Kelly and Jeff Mills. For access to live and exclusive video from CNBC subscribe to CNBC PRO:…
The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing. (July 22) Subscribe for more Breaking News: Website: Twitter: Facebook: Google+: Instagram: You…
Justine is one of the hundreds of volunteers who have put themselves forward for Imperial’s COVID-19 vaccine trial at their West London study facility. The multi-billion pound study first tested 15 participants, with no concerns, and is now widening to…
As Covid-19 cases spike in some countries, it’s clear that the pandemic isn’t slowing down. That’s why many are pinning their hopes on a vaccine. Thousands of scientists are now working on more than 150 vaccines, but none have been…
